Digital Health Startups

Help at Home provides in-home care services, matching trained caregivers with clients to deliver personalized support focused on maintaining health and independence. The company emphasizes long-term caregiver-client relationships, caregiver training, and preventive care to reduce hospitalizations and improve quality of life for elderly and vulnerable adults.

1 investor

Helpper operates a Flemish online platform that connects people needing help at home with screened local helpers for practical assistance, companionship, and care support. It serves budget holders (PVB/PAB), informal caregivers, seniors, and care professionals across Flanders and Brussels, and handles the relevant VAPH documentation.

1 investor

Hemeo develops AI-based clinical decision support software that consolidates data from multiple sources to predict coagulation risks and personalize the prevention and treatment of bleeding and thrombosis. It is aimed at doctors managing coagulation complications, with the goal of reducing blood transfusions and improving patient survival.

1 investor

Hemerion develops photonic drug-device combination therapies for treating glioblastomas and other brain tumors in clinical settings. The company combines photosensitizing drugs with innovative photonic systems designed to integrate into surgical workflows and selectively destroy tumor cells.

1 investor

HEMI provides a proprietary clinical AI platform serving hospitals, clinicians, and patients across Southeast Asia, with particular strength in Malaysia. The company owns its underlying AI models and offers medicolegal protection as a core architectural feature, differentiating it from licensed-model competitors.

1 investor

Global Point of Care provides portable point-of-care diagnostic analyzers and test systems for healthcare professionals to perform blood chemistry, lipid, and other diagnostic tests near the patient rather than in a central lab.

1 investor

Abbott Global Point of Care provides portable diagnostic analyzers and testing systems used at the point of care by healthcare professionals, enabling on-site blood chemistry, lipid, and other tests with results that can upload directly to electronic medical records. Its products serve clinical and near-patient testing settings in the in-vitro diagnostics category.

1 investor

Hera Women's Health partners with independent women's health providers to deliver clinical and operational support, modernizing practice operations while preserving physician independence and community relationships. The organization aims to improve healthcare delivery for women by removing administrative barriers and enabling providers to focus on patient care.

1 investor

Heran Partners is a venture capital firm investing in healthcare and life sciences companies that use enabling technologies—hardware, software, or services—to address unmet clinical needs and improve patient outcomes. The firm focuses on companies at seed through Series B stages that combine financial returns with societal impact by advancing treatments, generating actionable patient insights, or improving drug development efficiency.

1 investor

HeroSupport develops adaptive imaging and treatment tables for cancer radiotherapy that automatically adjust to individual patients, enhancing treatment precision and reducing discomfort for radiation oncology centers.

1 investor

HerSay offers an AI-powered health companion that helps women and underserved communities prepare for medical appointments, track symptoms, organize questions, and summarize doctor feedback to advocate for themselves. The product is aimed at women's health and patient self-advocacy in the healthcare system.

1 investor

Herself Health provides primary care services tailored for senior women covered by Medicare, with a focus on clinical, educational, and community support. The company operates in the Minneapolis/St. Paul area.

1 investor

Hertility Health offers at-home hormone and fertility testing along with clinical fertility and reproductive health services for women, covering symptom management, fertility planning, and perimenopause/menopause. It operates in the women's reproductive health and digital health space.

1 investor

Hexarad is a teleradiology and operational intelligence provider that matches medical scans to subspecialist radiologists and gives radiology teams real-time views of demand, capacity, and performance. It serves NHS and private healthcare providers, hospital system leaders, and radiology departments to speed diagnosis and reduce backlogs.

1 investor

OpenLoop is a white-label telehealth platform that enables healthcare brands to launch and scale virtual care services. The platform uses AI to streamline clinical workflows, manage patient support, and optimize care pathways across 30+ specialties nationwide.

1 investor

Amulet is a privacy-focused AI companion for older adults that provides personalized, proactive support and real-time monitoring to improve quality of life. It serves seniors and their family caregivers, aiming to reduce loneliness and help coordinate eldercare.

1 investor

Juna offers a weight loss program that includes medication and supporting ingredients, marketing results based on customer weight loss outcomes. It targets consumers seeking to lose weight.

1 investor

heyPatient builds a patient experience platform for healthcare providers that integrates with existing clinical and administrative systems to manage patient interactions across digital touchpoints, from appointment booking to post-care engagement. The company operates in Switzerland and is expanding to the US market, targeting specialist practices and ambulatory surgery center networks.

1 investor

Higgs Boson Health builds healthcare engagement and clinical trial management platforms, including tools for full-circle clinical trial management, custom voice-based AI agents, white-label digital therapy companions, and patient education across the care pathway. Its products serve healthcare systems, research teams, medical device companies, and pharma therapy providers.

1 investor

H.I.G. HealthBridge Capital Partners is a growth equity investment fund focused on healthcare companies across medical devices, biopharmaceuticals, digital health, diagnostics, and related services.

1 investor

Higher Prana builds immersive experiences using virtual reality and neuroscience-informed technologies to improve mental wellness, emotional resilience, and peak performance. The company serves individuals and organizations seeking to enhance cognitive function and mental health through measurable, trainable interventions.

1 investor

Highfield Diagnostics develops point-of-care diagnostic sensors using laser-based technologies on paper substrates, targeting detection of diseases like tuberculosis and leishmaniasis in resource-limited settings. The company applies laser engineering and microfluidics expertise to create affordable, low-cost diagnostic tests.

1 investor

HighTide Therapeutics is a biopharmaceutical company developing multifunctional therapies targeting cardiovascular-kidney-metabolic diseases. The company has a globally integrated pipeline with lead asset HTD1801 designated as a Fast Track and Orphan Drug candidate by the FDA.

1 investor

Higo builds medical infrastructure for remote, distributed healthcare, providing a device and platform that let doctors perform medical-grade examinations of patients at home rather than in clinics. It is developed with physicians from academic and medical institutions and targets families and healthcare systems.

1 investor